Comparison between levels of GPVI and α₂β₁ in myeloproliferative disorder and healthy donors. Levels of GPVI and α₂β₁ were measured by flow cytometry in platelet-rich plasma from 12 patients with essential thrombocythemia (ET) and 12 with polycythemia vera (PRV).